Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.595 AUD | -4.03% | -2.46% | -16.78% |
Apr. 30 | 4DMedical's Operating Revenue Grows 54% in Fiscal Q3 | MT |
Mar. 18 | 4DMedical Limited(ASX:4DX) added to S&P/ASX All Ordinaries Index | CI |
Sales 2024 * | 5.47M 3.58M | Sales 2025 * | 21.4M 14.01M | Capitalization | 233M 152M |
---|---|---|---|---|---|
Net income 2024 * | -30M -19.64M | Net income 2025 * | -22M -14.4M | EV / Sales 2024 * | 36.4 x |
Net cash position 2024 * | 34.05M 22.29M | Net cash position 2025 * | 17.15M 11.23M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-7.76
x | P/E ratio 2025 * |
-10.5
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.38% |
Latest transcript on 4DMedical Limited
1 day | -4.03% | ||
1 week | -2.46% | ||
Current month | -8.46% | ||
1 month | -7.75% | ||
3 months | -4.03% | ||
6 months | +20.20% | ||
Current year | -16.78% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 12-11-30 |
Simon Glover
DFI | Director of Finance/CFO | - | 22-07-24 |
Jon Dusting
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Figlin
BRD | Director/Board Member | - | - |
Julian Sutton
BRD | Director/Board Member | - | 17-08-31 |
Director/Board Member | 60 | 23-09-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.595 | -4.03% | 342 874 |
24-05-01 | 0.62 | +3.33% | 508,081 |
24-04-30 | 0.6 | -2.44% | 309,840 |
24-04-29 | 0.615 | +1.65% | 194,429 |
24-04-26 | 0.605 | +0.83% | 352,556 |
Delayed Quote Australian S.E., May 02, 2024 at 02:10 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.78% | 158M | |
+7.78% | 219B | |
+5.61% | 183B | |
+10.51% | 132B | |
+23.28% | 106B | |
-2.66% | 62.09B | |
+4.81% | 50.88B | |
+10.94% | 50.8B | |
-1.06% | 40.64B | |
+24.89% | 31.59B |
- Stock Market
- Equities
- 4DX Stock